By Andrew Silver SHANGHAI, April 22 (Reuters) - Pfizer’s GLP-1 weight management treatment Xianweiying is available for ...
Pfizer hasn't yet tapped into the highly lucrative market of diabetes drugs that have been increasingly used for weight loss purposes. Searching for a weight-loss drug but don't like the idea of an ...
Amylin drugs have become the next big thing in obesity. Eli Lilly CEO David Ricks, understandably, thinks his rivals don’t ...
Investor's Business Daily on MSN
Eli Lilly recovers after weight-loss patient reports a surprise side effect
Eli Lilly stock recovered Monday after a patient taking its new weight-loss pill, Foundayo, experienced liver failure.
Pfizer’s GLP-1 weight management treatment Xianweiying, is reportedly available for pre-order in China in the wake of ...
Pfizer Inc. (NYSE:PFE) is included among the 14 Low PE High Dividend Stocks to Buy Right Now. On March 6, Reuters reported that China has approved Pfizer Inc. (NYSE:PFE)’s GLP-1 treatment Xianweiying ...
A new GLP-1 weight loss drug called survodutide has shown promising results in a phase 3 clinical trial. The drug, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results